Correlation Between Crinetics Pharmaceuticals and Verona Pharma

Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crinetics Pharmaceuticals and Verona Pharma PLC, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Verona Pharma.

Diversification Opportunities for Crinetics Pharmaceuticals and Verona Pharma

0.79

Correlation Coefficient

Crinetics Pharmaceuticals  Verona Pharma

Poor diversification

The 3 months correlation between Crinetics and Verona is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Verona Pharma go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Verona Pharma

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 3.16 times less return on investment than Verona Pharma. But when comparing it to its historical volatility, Crinetics Pharmaceuticals is 1.24 times less risky than Verona Pharma. It trades about 0.08 of its potential returns per unit of risk. Verona Pharma PLC is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  2,703  in Verona Pharma PLC on September 5, 2024 and sell it today you would earn a total of  1,163  from holding Verona Pharma PLC or generate 43.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Crinetics Pharmaceuticals  vs.  Verona Pharma PLC

Crinetics Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Verona Pharma PLC

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Crinetics Pharmaceuticals and Verona Pharma

The main advantage of trading using opposite Crinetics Pharmaceuticals and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.

The idea behind Crinetics Pharmaceuticals and Verona Pharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..